Yiming Biotech Win the 2020 Jiangsu Strategic Emerging Industry Special Fund
On 28 June 2020, the Department of Finance of Jiangsu Province issued 41 projects and investment plans of provincial-level special funds for the development of emerging industries. The R&D and industrialization project of transglutaminase (TG) based on multi-scale optimization, undertaken by Jiangsu Yiming Biological Co., Ltd., ranked among them.
The project started in 2019 and is expected to end in 2021 with a total investment of 150 million yuan. It is based on high-throughput screening and the company's unique mutation technology. Through high-yield strain optimization, fermentation process optimization, production control and other key technological breakthroughs, the technical indicators such as enzyme yield, fermentation time and enzyme activity are all leading in China, breaking the monopoly of foreign technology and filling the international gap. After the completion of the project, the annual TG output is expected to reach 3,000 tons with annual sales income increasing by 200 million yuan.